These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29542281)

  • 21. The impact of coronary artery disease severity on long-term outcomes in unprotected left main coronary artery revascularization.
    Kahraman S; Zencirkiran Agus H; Demirci G; Can C; Demir AR; Güner A; Kalkan AK; Uzun F; Ertürk M; Yıldız M
    Turk Kardiyol Dern Ars; 2021 Jan; 49(1):8-21. PubMed ID: 33390575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial.
    Mennuni MG; Dangas GD; Mehran R; Ben-Gal Y; Xu K; Généreux P; Brener SJ; Feit F; Lincoff AM; Ohman EM; Hamon M; Stone GW
    J Invasive Cardiol; 2015 Oct; 27(10):468-73. PubMed ID: 26121708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of baseline and residual SYNTAX scores in cardiogenic shock.
    Javanainen T; Sans-Roselló J; Harjola VP; Nieminen MS; Lassus J; Sionis A; Varpula M; Jurkko R
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):1-8. PubMed ID: 30208254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Gao G; Zhang D; Song C; Xu H; Yin D; Guan C; Yang Y; Xu B; Dou K
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():534-541. PubMed ID: 31876352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
    Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
    Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Incomplete Revascularization on Long-Term Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention.
    Azzalini L; Candilio L; Ojeda S; Dens J; La Manna A; Benincasa S; Bellini B; Hidalgo F; Chavarría J; Maeremans J; Gravina G; Miccichè E; D'Agosta G; Venuti G; Tamburino C; Pan M; Carlino M; Colombo A
    Am J Cardiol; 2018 May; 121(10):1138-1148. PubMed ID: 29563016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial.
    Blazek S; Rossbach C; Borger MA; Fuernau G; Desch S; Eitel I; Stiermaier T; Lurz P; Holzhey D; Schuler G; Mohr FW; Thiele H
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):30-8. PubMed ID: 25499302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery.
    Armstrong EJ; Graham LA; Waldo SW; Valle JA; Maddox TM; Hawn MT
    JACC Cardiovasc Interv; 2017 Feb; 10(4):329-338. PubMed ID: 28161261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry.
    Chandrasekhar J; Baber U; Sartori S; Aquino M; Tomey M; Kruckoff M; Moliterno D; Henry TD; Weisz G; Gibson CM; Iakovou I; Kini A; Faggioni M; Vogel B; Farhan S; Colombo A; Steg PG; Witzenbichler B; Chieffo A; Cohen D; Stuckey T; Ariti C; Pocock S; Dangas G; Mehran R
    Int J Cardiol; 2017 Sep; 243():132-139. PubMed ID: 28554669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
    Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score.
    Généreux P; Palmerini T; Caixeta A; Rosner G; Green P; Dressler O; Xu K; Parise H; Mehran R; Serruys PW; Stone GW
    J Am Coll Cardiol; 2012 Jun; 59(24):2165-74. PubMed ID: 22483327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Residual SYNTAX Score and Its Derived Indexes on Clinical Outcomes after Percutaneous Coronary Intervention: Data from a Large Single Center.
    Song Y; Gao Z; Tang XF; Jiang P; Xu JJ; Yao Y; Li JX; Zhao XY; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Chin Med J (Engl); 2018 Jun; 131(12):1390-1396. PubMed ID: 29893355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study.
    Xu B; Yang YJ; Han YL; Lu SZ; Li B; Liu Q; Zhu GY; Cui JY; Li L; Zhao YL; Kirtane AJ;
    EuroIntervention; 2014 May; 10(1):65-73. PubMed ID: 24603020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
    Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
    Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive value of combining the SYNTAX score with reactive hyperemia index in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    He Y; Cheng XF; Wang K; Liu T; Fan HP; Pan WX; He PX; Jin J
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):E130-E139. PubMed ID: 31254447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.